Although not reaching statistical significance, a trend toward higher AKI occurrence was observed among patients receiving ARBs (33.33% vs. 12.50%, p = 0.073), consistent with the known perioperative risk of renin-angiotensin system blockade. This evidence concerns the gene REN and acute kidney injury.